For the last decade, Colin Dykes has been setting up and running genomics shops. He began by devising Glaxo’s genomics program in 1993, and in 1998 joined Variagenics, where he guided the company over the last four years as vice president of research. Now, the Northern Ireland native has relocated to Madison, Wis., where he assumes the role of CSO at optical mapping company OpGen.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.